Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$9.99 - $14.41 $159,840 - $230,560
-16,000 Reduced 37.5%
26,667 $291,000
Q2 2020

Aug 14, 2020

BUY
$12.28 - $17.63 $327,470 - $470,139
26,667 Added 166.67%
42,667 $588,000
Q4 2018

Feb 14, 2019

BUY
$3.35 - $5.68 $53,600 - $90,880
16,000 New
16,000 $64,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $10.1M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.